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Background: To organize tailored healthcare for people with multiple sclerosis (MS), knowledge about patterns in
the use of healthcare among subgroups, such as those with depressive symptoms, is essential. Thus, the purpose of
this study was to explore and compare the use of health services in people with MS and depressive symptoms, and
without depressive symptoms over a period of 30 months.
Methods: Data on the use of health services by 71 people with MS and depressive symptoms, and 102 with no
depressive symptoms were collected from a computerised register and by interview, then categorized with regard
to disease severity (Expanded Disability Status Scale).
Results: People with EDSS mild and depressive symptoms used more outpatient and inpatient care compared to
those with no depressive symptoms. Furthermore, they received more unsalaried informal care as well as intense
rehabilitation periods.
Conclusions: The issues underlying the differences in the use of healthcare need to be explored further, as well as
the plausible implications for the organization of healthcare services for people with MS and depressive symptoms.
Furthermore, the life situations of caregivers of people with MS and depressive symptoms should be considered,
and appropriate interventions supplied in order to diminish caregiver burden.
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ObservationalBackground
Studies on the use of healthcare among people with
multiple sclerosis (MS) show that large proportions
use hospital care and primary care in parallel with
many different departments and services involved [1].
In addition, the use of healthcare may vary in different
subgroups of people with MS, as seen with regard to
fatigue [2], and depressive symptoms [3], for example,
although results are conflicting [4].
Several studies show that the prevalence of depression
among people with MS is higher compared to the
general population [5], varying between 26% and 42%* Correspondence: charlotte.ytterberg@ki.se
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reproduction in any medium, provided the or[5-7], as well as when compared to people with other
chronic conditions [5]. There is evidence that depressive
symptoms in people with MS are strongly associated with
worse self-reported functioning and low health-related
quality of life [8,9]. Furthermore, associations between
depressive symptoms and fatigue have also been reported
[10,11], as well as associations with impaired cognition,
although results are inconsistent [7,12]. People with MS
and depressive symptoms have a lower coping capacity [7]
use less-effective coping strategies, (e.g., avoidance) [13],
and also perceive less social support from their families
and friends [14]. It has also been found that they have
more lost days from work [15]. Depressive symptoms can
negatively impact the progression of MS, since depressed
people with MS are less likely to adhere to immunomodu-
latory treatment [16]. Depressive symptoms in people withral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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suicide [17].
Recommendations of treatment for depression in MS
include pharmacologic or psychotherapeutic approaches,
or preferably a combination of both [18]. Nevertheless,
depressive symptoms have been found to be undertreated
[19,20], and despite a high level of general satisfaction
with healthcare in people with MS, many experience a
lack of psychosocial support [21]. Furthermore, the use of
healthcare has been shown to vary in different subgroups
of people with MS [2], but it is not known whether the
use varies also among people with MS with or without
depressive symptoms. Therefore, to plan for and organize
tailored healthcare for people with MS, it is important to
have knowledge about patterns in the use of healthcare
among different subgroups, such as those who also have
depressive symptoms. Thus, the aim of this study was to
explore and compare the use of health services in people
who have MS and depressive symptoms, and without
depressive symptoms over a period of 30 months.
Methods
Participants and procedures
Data were collected in the context of a prospective,
observational study of functioning, perceived health and
the use of healthcare among people with MS. All people
with MS who were scheduled for an outpatient visit with
one of two senior neurologists at the MS Centre of the
Department of Neurology at Karolinska University
Hospital, Huddinge, in Stockholm, Sweden during the
period from February 1, 2002 to June 12, 2002, were
eligible for inclusion and 219 people with MS were
included in the study after securing informed consent.
Follow-ups were performed every six months for two
years, with 200 people completing the full study. During
inclusion, and then at 6, 12, 18 and 24 months, the people
with MS met an investigator, one of five research physio-
therapists trained to perform the tests according to a
standardized procedure, primarily the same investigator,
and at the same time of day on all occasions. Detailed
descriptions of demographic and disease-related data in
the sample have been reported elsewhere [22]. The study
was approved by the ethical review board of Karolinska
Institutet in Stockholm, Sweden.
Data collection
The neurologist responsible assessed disease severity
using the Expanded Disability Status Scale (EDSS) [23];
scores were categorized as EDSS mild (EDSS 0–3.5),
EDSS moderate (EDSS 4.0–5.5) or EDSS severe (EDSS
6.0–9.5) and determined the disease course (relapsing
remitting, secondary progressive, primary progressive).
The remaining data were collected by the research
physiotherapists. Demographic- and disease-related datawere collected both by means of interviews and from the
medical records.
The Beck Depression Inventory (BDI) [24] was employed
at inclusion as well as at 12 and 24 months to assess mood –
depressive symptoms. The BDI has been recommended as a
screening measure for depression in people with MS
[18] and consists of 21 symptoms related to depression, 20
of which are self-rated from 0 (absent) to 3 (severe), and
then one item from 0 (absent) to 2 (severe). The ratings for
each item make up the total score, ranging from 0 to 62.
The cut-off was a score of equal to or greater than 13 for
depressive symptoms, which is in line with current recom-
mendations [18]. The people with MS were categorized
into those with Depressive symptoms (BDI score ≥ 13 at
one or more points of data collection), and those with No
depressive symptoms (BDI score < 13) throughout the
study. The present study is an analysis based on the 173
people with MS who completed the BDI on all three
occasions of data collection in the 2-year study and
were residents within Stockholm County. A total of
27 people with MS who lacked a BDI score at one or more
points of data collection (n = 15), or were residents outside
of Stockholm County (n = 12), were not included.
Data on the use of inpatient (days) and outpatient
(contacts) healthcare services were obtained from the
computerised register of the Stockholm County Council.
This register contains information regarding all healthcare
contacts with care providers organized by the Stockholm
County Council that have rendered notes (documentation
of care) in the medical records. The types of outpatient
contacts recorded in the register include visits, telephone
consultations, and home visits. Searches were carried out
for the whole study period, beginning six months before
inclusion, and lasting until the data collection ended at
24 months, in total a period of 30 months.
Total outpatient care included both hospital outpatient
care and primary care. Concerning outpatient neurology
care and outpatient primary care, data were analyzed
according to type of healthcare profession: physician;
nurse; nurse aid; welfare officer; psychologist; occupational
therapist; physiotherapist; dietician; and speech and lan-
guage therapist. Data regarding the use of other healthcare
services during the previous six months such as home-help
services; salaried personal assistants; unsalaried informal
care from partners and others; transportation service for
the disabled; and periods of intense rehabilitation services
at rehabilitation units organised by the private sector, were
collected by interview according to a protocol at each point
of data collection, thus covering a period of 30 months. A
similar methodology has previously been used [1,2].
Statistical analysis
Descriptive statistics were used to present demographic-
and disease-related data and use of healthcare services
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severity. The use of healthcare services was analysed with
regard to disease severity, and categorized as EDSS mild,
EDSS moderate, and EDSS severe. The Mann Whitney-U
test was used for analyses of differences between people
with MS with depressive symptoms versus no depressive
symptoms in their use of healthcare services. For
analyses of differences in other health services with
regard to disease severity, the chi-square test was
used. P-values less than or equal to 0.05 were considered
statistically significant.
Results
Demographic- and disease-related data at inclusion are
presented in Table 1. Depressive symptoms were found in
71 (41%) people with MS at one or more points of data
collection, whereas 102 (59%) had no depressive symptoms
throughout the two-year study. Among the 111 people
with MS and EDSS mild, 39 (35%) had depressive symp-
toms, whereas 72 (65%) had no depressive symptoms.
Thirty people with MS had EDSS moderate, 16 (53%) with,
and 14 (47%) without depressive symptoms; of the 32
that had EDSS severe, there were 16 (50%) with, and
16 (50%) without depressive symptoms. The use of
antidepressant drugs in people with depressive symp-
toms varied from 28% among those with EDSS mild,
to 38% among those with EDSS moderate (Table 1,
footnote a-c).Table 1 Demographic- and disease-related data at inclusion f






n = 173 n = 39a n = 7
Women, n (%) 116 (67) 28 (72) 51 (71
Mean age, years (sd) 46 (12) 42 (13) 43 (11
Cohabiting, n (%) 123 (71) 31 (79) 51 (71
Working full- or part-time, n (%)d 114 (66) 24 (65) 59 (84
Immunomodulatory treatment, n (%) 146 (84) 30 (77) 57 (79
Mean years since diagnosis, (sd) 13 (10) 9 (7) 12 (10
Disease severity, n (%)
EDSS mild 1.0-3.5 111 (64) 1.8 (1.0-3.5) 1.8 (1.0-
EDSS moderate 4.0-5.5 30 (17)
EDSS severe 6.0-9.5 32 (18)
Disease course, n (%)
Relapsing remitting 106 (61) 35 (90) 62 (86
Secondary progressive 58 (34) 1 (2) 7 (10
Primary progressive 9 (5) 3 (8) 3 (4)
a11 (28%) people with MS used antidepressant drugs.
b6 (38) people with MS used antidepressant drugs.
c5 (31%) people with MS used antidepressant drugs.
dbased on PwMS < 65 years, n = 159.Hospital care (outpatient and inpatient) and primary care
All people with MS involved in the study had been in
contact with hospital outpatient care. Among people
with depressive symptoms, a larger proportion, 96%,
had contacts within primary care, compared to 84%
among those with no depressive symptoms (p = 0.006).
Furthermore, among people with depressive symptoms, a
larger proportion, 32%, had received inpatient care,
compared to 16% among those with no depressive
symptoms (p = 0.01).
Among people with EDSS mild, larger proportions of
those with depressive symptoms compared to those with
no depressive symptoms were found receiving care from
the following areas: nurses in hospital outpatient care
(85% vs 61%, p = 0.01); speech/language therapists in
hospital outpatient care (8% vs 0%, p = 0.04); psychiatric
departments (20% vs 0%, p < 0.001); other departments
(64% vs 43%, p = 0.03); total primary care (95% vs 79%,
p = 0.02); and inpatient care (28% vs 12%, p = 0.02).
Table 2 presents the number of users of healthcare
services, the number of outpatient contacts, and the days
of inpatient care, all categorized with respect to the pres-
ence or absence of depressive symptoms, and with
regard to disease severity. Among people with EDSS
mild, those with depressive symptoms were found to
have a larger number of healthcare contacts with regard
to total hospital outpatient care and to have utilised the
following healthcare professionals: neurologists; nurses;or the total sample and with respect to presence or
severity











2 n = 16b n = 14 n = 16c n = 16
) 9 (56) 7 (47) 10 (62) 11 (69)
) 47 (9) 55 (10) 56 (11) 53 (12)
) 11 (69) 9 (64) 11 (69) 11 (69)
) 7 (47) 7 (64) 0 7 (46)
) 15 (94) 14 (100) 14 (88) 16 (100)
) 15 (10) 15 (10) 19 (9) 20 (11)
3.5)
4.7 (4.0-5.5) 4.6 (4.0-5.5)
7.3 (6.0-8.0) 7.0 (6.0-8.0)
) 3 (19) 4 (29) 0 2 (13)
) 12 (75) 9 (64) 16 (100) 13 (81)
1 (6) 1 (7) 0 1 (6)
Table 2 Use of healthcare services categorized with respect to presence or absence of depressive symptoms and with
regard to disease severity; number of users, number of outpatient contacts and days of inpatient care during
30 months
EDSS mild (Number of users),
mean/median/range
EDSS moderate (Number of users),
mean/median/range















n = 39 n = 72 n = 16 n = 14 n = 16 n = 16
Hospital outpatient care,
total
(39) (72) (16) (14) (16) (16)





Neurologist (39) (72) (16) (14) (16) (16)





Nurse (33) (44) (13) (10) (11) (10)
3.2/2/0-14 1.7/1/0-10 0.002 2.7/3/0-7 2.2/2/0-9 0.22 1.8/2/0-7 1.4/1/0-7 0.47
Welfare officer (14) (15) (7) (4) (1) (4)
3.8/0/0-33 0.7/0/0-13 0.03 5.8/0/40 2.4/0/0-12 0.43 0.1/0/0-1 0.8/0/0-6 0.14
Physiotherapist (8) (10) (10) (3) (4) (6)
1.9/0/0-35 2.7/0/0-129 0.39 5.9/0/0-53 11.2/0/0-83 0.15 5.0/0/0-46 7.3/0/0-36 0.45
Occupational
therapist
(6) (8) (3) (1) (3) (3)
0.4/0/0-5 0.4/0/0-9 0.55 0.8/0/0-11 0.1/0/0-2 0.40 0.2/0/0-2 1.0/0/0-11 0.91
Dietician (3) (4) (4) (1) (2) (5)
0.1/0/0-2 0.1/0/0-4 0.70 0.3/0/0-2 0.1/0/0-1 0.19 0.2/0/0-2 0.3/0/0-1 0.27
Speech/language
therapist
(3) 0 (2) (2) (2) (4)
0.0/0/0-8 0.02 1.4/0/0-18 0.1/0/0-1 1.0 0.8/0/0-11 0.6/0/0-6 0.42
Psychologist (3) (9) (1) (1) (4) 0
0.3/0/0-6 0.9/0/0-42 0.47 0.1/0/0-1 0.2/0/0-3 0.10 1.3/0/0-7 0.04
Emergency
Room
(13) (22) (6) (4) (5) (6)
0.7/0/0-8 0.4/0/0-4 0.62 0.6/0/0-3 0.2/0/0-1 0.44 0.5/0/0-4 0.6/0/0-3 0.64
Ophthalmology (10) (15) (5) (2) (2) (4)
0.6/0/0-6 0.6/0/0-19 0.56 0.6/0/0-6 0.3/0/0-4 0.32 0.1/0/0-1 0.3/0/0-2 0.36
Urology (3) (5) (1) (2) (6) (5)
0.3/0/0-13 0.2/0/0-7 0.91 0.1/0/0-1 0.5/0/0-4 0.76 1.6/0/0-10 1.1/0/0-6 0.69
Psychiatry (8) 0 (3) (1) 0 0
2.6/0/0-64 <0.001 1.9/0/0-27 0.1/0/0-1 0.34
Othera (25) (31) (12) (7) (11) (9)
49.0/0/0-33 2.1/0/0-47 0.01 6.0/1/0-38 2.4/0/0-15 0.62 5.9/2/0-25 3.3/2/0-18 0.47








Physician (33) (51) (14) (12) (9) (16)
3.5/2/0-12 3.3/2/0-31 0.24 3.3/3/0-17 3.3/2/0-10 0.80 6.1/4/0-21 3.4/2/1-7 0.85
Nurse (18) (39) (12) (8) (16) (15)







(6) (4) (9) (4) (13) (11)
0.4/0/0-7 0.2/0/0-7 0.08 3.0/2/0-14 1.5/0/0-9 0.20 10.2/7/0-61 5.1/3/0-19 0.27
Physiotherapist (7) (5) (6) (3) (11) (9)
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Table 2 Use of healthcare services categorized with respect to presence or absence of depressive symptoms and with
regard to disease severity; number of users, number of outpatient contacts and days of inpatient care during
30 months (Continued)
3.7/0/0-98 0.8/0/0-42 0.07 8.6/0/0-94 4.3/0/0-28 0.46 30.0/11/0-
147
15.0/4/0-56 0.44
Nurse aid (3) (7) (5) (1) (10) (5)
0.2/0/0-5 0.5/0/0-30 0.76 4.9/0/0-57 0.1/0/0-1 0.09 16.8/3/0-
121
8.2/0/0-107 0.10
Psychologist 0 0 (2) 0 (2) (1)
1.8/0/0-19 0.19 0.2/0/0-3 0.6/0/0-11 0.63
Dietician 0 0 0 0 (1) 0.1/0/0-2 0 0.35
Welfare officer (2) 0 0 (1) 0 0
0.1/0/0-3 0.06 3.0/0/0-42 0.32
Hospital inpatient careb,c (11) (9) (5) (1) (7) (6)
3.9/0/0-75 0.5/0/0-8 0.04 4.4/0/0-29 1.0/0/0-14 0.28 9.3/0/0-79 2.2/0/0-13 0.47
aDermatology, endocrinology, gynecology, hematology, medicine, oncology, surgery.
bGynecology, neurology, medicine, infection, orthopedics, psychiatry, surgery.
cDays.
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departments; and other departments. There was no dif-
ference regarding the number of hospital outpatient
contacts with psychologists. With regard to total primary
care, there was a larger number of healthcare contacts
among people with depressive symptoms. No people with
MS and EDSS mild had been in contact with psychologists
within primary care. There was also a tendency to have a
larger number of contacts with welfare officers within
primary care among people with depressive symptoms.
The number of days in inpatient care was larger among
those with depressive symptoms.
Among people with EDSS moderate, no differences
were found in proportions of users, number of contacts
within hospital outpatient care, primary care or in number
of days spent in inpatient care between people with, versus
without, depressive symptoms.
Among people with EDSS severe and with depressive
symptoms, the few areas of difference were a largerTable 3 Use of salaried services, informal care and of other ty
respect to presence or absence of depressive symptoms and
receiving the services during 30 months










Personal assistance 2 (5) 0 0.12 2 (1
Home help service 1 (3) 0 0.35 2 (1
Informal care 35 (90) 6 (8) 0.02 14 (
Intense rehabilitation period 11 (28) 8 (11) 0.02 13 (
Transportation service for
the disabled
8 (20) 6 (8) 0.06 15 (number of contacts with hospital outpatient psycholo-
gists, the total use of primary care, and the use of nurses
within primary care. There were no differences regarding
the number of hospital outpatient contacts with welfare
officers or psychologists within primary care. No people
with EDSS severe had been in contact with psychiatric
departments or with welfare officers within primary care.
Other health services
Use of other health services in people with MS, catego-
rized with respect to presence or absence of depressive
symptoms and with regard to disease severity, is presented
in Table 3. Among people with EDSS mild, larger propor-
tions of those with depressive symptoms received informal
care from partners and others, and larger proportions
had undergone intense rehabilitation periods compared to
people with no depressive symptoms. Among people
with EDSS moderate and EDSS severe, no differences
were found.pes of services in people with MS, categorized with
with regard to disease severity; number of people














2) 0 0.48 6 (38) 7 (44) 0.72
2) 4 (29) 0.38 8 (50) 6 (38) 0.48
88) 13 (93) 0.62 16 (100) 14 (88) 0.48
81) 8 (57) 0.15 12 (75) 13 (81) 0.67
94) 10 (71) 0.10 16 (100) 16 (100) 1.00
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This study explored the use of health services in people
with MS, with and without depressive symptoms during
a period of 30 months, with regard to disease severity.
The results showed that people with EDSS mild and
depressive symptoms used more hospital outpatient care
and primary care, and spent more days in inpatient care
compared to people with EDSS mild and no depressive
symptoms. Furthermore, the results showed that those
people with EDSS mild and depressive symptoms
received more informal care and intense rehabilitation
periods than did people with EDSS mild with no depressive
symptoms.
The larger amount of contacts with welfare officers in
hospital outpatient care and contacts with psychiatric
departments among people with EDSS mild and depres-
sive symptoms is not surprising, and may in fact reflect
an adequate supply of healthcare in line with current
recommendations of treatment for depression in people
with MS [18]. On the other hand, no clear pattern of
healthcare use with regard to specific services was found,
but instead, there was a noticeable general increase
involving a number of different services. Similar results
were found in a previous study of healthcare use among
people with MS and fatigue based on the same cohort of
people [2]. However, in the present study, the types of
services where an increased use were found differ from
the previous study; two examples of this would be the
larger number of contacts with nurses in outpatient
hospital care, and more total days spent in inpatient
care. There are several possible explanations for these
results. It has been shown that patients rate the impact
of mental health as more important than their physicians
do [25], and that people with disability differ in their
perception of rehabilitation needs compared with their
nominated key professionals [26]. Furthermore, depres-
sive symptoms among people with MS have been found
to be undertreated [27], and only a minority of those
with depressive symptoms in the present study used
antidepressant drugs. Thus, the increased use of health
services may reflect that depressive symptoms were not
noted or not adequately treated, therefore leading to
repeated contacts with the healthcare system. Other
possible explanations for the results could be that people
with MS and depressive symptoms perceive their disabil-
ity as being greater than their physicians' perception
[28]. Another possibility is that depressive symptoms are
associated with secondary health conditions and so an
increased use of healthcare follows, as shown in a previ-
ous study [3]. Since people with MS and depressive
symptoms have been shown to use less-effective coping
strategies [13], it is also plausible that they are more
dependent on the healthcare system in the absence of
self-management strategies.No differences in the use of health services were found
among people with MS and EDSS moderate, while those
with EDSS severe coupled with depressive symptoms
had more contacts with several healthcare professionals
compared to those with EDSS severe and no depressive
symptoms. However, the differences in use of health
services among people with EDSS severe were not as
evident compared with people with EDSS mild. The
differences in the use of health services with regard to
disease severity may partly be attributed to the fact that
the EDSS mild group was the largest, while the other
groups of disease severity may have lacked statistical
power to detect differences. Another plausible explanation
might be that among people with EDSS moderate and
EDSS severe, there are many other disabilities besides
depressive symptoms that contribute to an increased
need for use of health services.
Psychiatric symptoms, such as depressive symptoms,
for example, in people with MS are associated with high
levels of distress among caregivers [29]. The finding in
the present study that those with depressive symptoms
also received more unsalaried informal care from partners
and others adds further insights of the caregiver burden
among caregivers to people with both MS and depressive
symptoms. Caregiver burden is a very important issue
with MS, since it is generally diagnosed in young
adults, and many years of future caregiving are often
involved. Recognition of caregiver burden is important
in determining appropriate interventions for the families
of people with MS [30].
The major strengths of the present study were the
longitudinal design covering 30 months; the use of
the BDI, a recommended screening measure for depressive
symptoms in people with MS [18]; and the reliable data on
healthcare use derived from the computerised register at
the Stockholm County Council. However, data on the use
of other healthcare services were collected by interview,
and may thus be biased by the difficulties to recall informa-
tion among the people with MS. Further, the groups of
people with EDSS moderate and EDSS severe were quite
small and may have lacked statistical power to detect
differences in the use of healthcare services. The results
should also be interpreted bearing in mind that the study
was carried out within the Swedish healthcare system
and differences in organisation and policies need to
be considered before the results can be generalized to
other healthcare systems.
Conclusions
In conclusion, this study revealed a higher use of health
services among people with both MS and depressive
symptoms in comparison with those without depressive
symptoms, especially among people with EDSS mild.
The issues underlying these differences need to be
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for the organization of health services for people with MS
and depressive symptoms. Furthermore, the life situations
of caregivers of people with EDSS mild and depressive
symptoms should be considered, and appropriate inter-
ventions supplied in order to diminish caregiver burden.
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